ARCHIVES

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout

May 17, 1974

Clinical Oncology Program Overview Updates Ongoing Trials

December 8, 1989